Endoskopi
Kolonoskopi
ERCP
ESD
EMR
EUS
Crohn Hastalığı
Ülseratif Kolit
Reflü
Gastrit
Ph metri
Manometri
Kapsül Endoskopi
Perkütan Endoskopik Gastrostomi
Çölkay Hastalığı
Safra kesesi ve Safra Yolu Hastalıkları
Pankreatit
Sindirim Sistemi Kanamaları
Hepatit B
Hepatit C
Karaciğer Sirozu
A. Uluslararası hakemli dergilerde yayımlanan makaleler :
1. MUTLUAY SOYER OZLEM, BARAN BULENT, ORMECİ ASLI CIFCIBASI, SAHİN DAVUT, GOKTURK SUUT, EVİRGEN SAMİ, BASAR RAFET, FIRAT PINAR, AKYUZ FİLİZ, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN, KARACA CETİN. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study. Medicine (Baltimore). 2017 Jan;96(1):e5513. doi: 10.1097/MD.0000000000005513.
2. ORMECİ ASLI, AYDIN YÜCEL, SUMNU ABDULLAH, BATAN BULENT, MUTLUAY SOYER OZLEM, PINARBASI BİNNUR, GOKTURK SUUT, GULLUOGLU MİNE, ONEL DERYA, BADUR SELİM, AKYUZ FİLİZ, KARACA CETİN, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels. Int J Infect Dis. 2016 Nov;52:68-73. doi: 10.1016/j.ijid.2016.09.007.
3. KARACA CETİN, DAGLILAR EBUBEKIR, MUTLUAY SOYER OZLEM, GULLUOGLU MİNE, BRUGGE WİLLİAM R. Endoscopic submucosal resection of gastric subepithelial lesions smaller than 20 mm: a comparison of saline solution-assisted snare and cap band mucosectomy techniques.Gastrointest Endosc. 2016 Sep 20. pii: S0016-5107(16)30585-5. doi: 10.1016/j.gie.2016.09.016.
4. MUTLUAY SOYER OZLEM, PEHLİVAN ASLI, CIFCIBASI ORMECI, BARAN BULENT, SAHİN TOLGA Rabbit syndrome developing during peginterferon alfa-2a use in chronic hepatitis C. Curr Med Res Opin. 2017 Jan;33(1):55-56. DOI:10.1080/03007995.2016.1233100.
5. MUTLUAY SOYER ÖZLEM,BARAN BULENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA, ÖNEL DERYA,GÜLLÜOGLU MINE,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Comparison of the efficacy of 12 months and
longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study. Postgraduate Medicine, 1-7., Doi: 10.1080/00325481.2016.1175310.
6. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT, EVIRGEN SAMI,BOZBEY HAMZA UGUR,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, ÖNEL DERYA,GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2013). Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy, 57(4), 1790-1796., Doi: 10.1128/AAC.02600-12.
7. BARAN BULENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA, GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2015). Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B
virus. Liver International, 35(10), 2265-2274., Doi: 10.1111/liv.1283.
8. KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,BARAN BÜLENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2012). Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of response. Antiviral Therapy, 18(4), 561-566.,
Doi: 10.3851/IMP2381.
9. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2014). Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C. Journal of Viral Hepatitis, 21(2),
111-120., Doi: 10.1111/jvh.12127.
10. YILMAZ EMRE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÖNEL MUSTAFA,ÖNEL DERYA,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,KARACA ÇETIN (2014). Effects of Polymorphisms in Interferon λ 3(Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection. Clinical Gastroenterology and Hepatology, 12(10), 1753-1758., Doi: 10.1016/j.cgh.2014.01.043.
11. ÇIFCIBASI ÖRMECI ASLI,AKYÜZ FILIZ,BULENT BARAN,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,ÖNEL MUSTAFA,ÖNEL DERYA,AGAÇFIDAN ALI,DEMIRCI MEHMET,YEGEN GÜLÇIN,GÜLLÜOGLU MINE,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. European Review for Medical and Pharmacological Sciences.
12. ÖRMECI ASLI,EMRENCE ZELIHA,BARAN BULENT,SUUT GÖKTÜRK,MUTLUAY SOYER ÖZLEM, EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN, ÜSTEK DURAN,DEMIR KADIR (2016). Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. European Review for Medical and Pharmacological Sciences.
13. DEMIR ABDURRAHMAN,AKYÜZ FILIZ,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ ÜMIT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN,DEMIR KADIR,GÜNDOGDU GÖKCEN,GÜLLÜOGLU MINE, ERER SAIT BURAK,KAMALI SEVIL,KAYMAKOGLU SABAHATTIN, BESISIK SELMAN FATIH,GÜL AHMET(2014). Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scandinavian Journal of Gastroenterology, 49(12), 1414-1418., Doi:10.3109/00365521.2014.976838.
14. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2016). What is the impact of capsule endoscopy in the long term period?. World Journal of Gastrointestinal Endoscopy, 8(7), 344, Doi: 10.4253/wjge. v8.i7.344.
15. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,POYANLI ARZU,KARACA ÇETIN (2013). Angiographic embolization of large duodenal varix in a cirrhotic patient. Digestive and Liver Disease, 45
(5), 437, Doi: 10.1016/j.dld.2012.10.001.
16. BARAN BULENT,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN (2013). Terry's nail: an overlooked
physical finding in cirrhosis. Hepatobiliary & Pancreatic Diseases International, 12(1), 109, Doi:
10.1016/S1499-3872(13)60017-X, (Kontrol No: 2701720)
17. KARACA ÇETIN,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM (2012). Unusual location of
polypectomy with an ultra-slim gastroscope: Biliary polyp (with video). Digestive Endoscopy, 24(6), 477-477., Doi: 10.1111/j.1443-1661.2012.01323.x.
18. BARAN BULENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,LAÇIN SAHIN,DEMIR KADIR,BESISIK SELMAN FATIH,BOZTAS GÜNGÖR (2012). Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report. Clinics and Research in Hepatology and Gastroenterology, 36(4), 69-70., Doi: 10.1016/j.clinre.2012.01.002.
19. BARAN BÜLENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,YÖNAL IPEK,ISIKLAR AYSUN,ÇAKMAK RAMAZAN,NALÇACI MELIHA,DOGAN ÖNER,KAYMAKOGLU SABAHATTIN (2013). Rosai–Dorfman disease with diffuse gastrointestinal involvement. European Journal of Gastroenterology & Hepatology, 25(7), 869-874., Doi: 10.1097/MEG.0b013e32836019f8.
20. ASLI ÇIFCIBASI ÖRMECI, EMRENCE ZELIHA, BÜLENT BARAN, SOYER ÖZLEM, GÖKTÜRK SUUT, EVIRGEN SAMI, AKYÜZ FILIZ, KARACA ÇETIN, BESISIK SELMAN FATIH, KAYMAKOGLU
SABAHATTIN, ÜSTEK DURAN, DEMIR KADIR (2016). Can helicobacter pylori be eradicated with
high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotipic
polymorphism?. European Review for Medical and Pharmacological Sciences,
21. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLUSABAHATTIN,BESISIK SELMAN FATIH (2016). Retention during capsule endoscopy: Is it a real problem in routine practice?. Journal of International Medical Research, Doi: 10.1177 /0300060516645420.
22. GÖKTÜRK SUUT,ATAY KADRI,ÖRMECI ASLI,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,KAYMAKOGLU SABAHATTIN (2011). A rare complication of interferon treatment: optic neuropathy. Annals of Gastroenterology.
23. AKYÜZ F, MUTLUAY SOYER Ö (2017). Which diseases are risk factors for developing gastroesophageal reflux disease? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol.Dec;28(Suppl 1):S44-S47. doi:10.5152/tjg.2017.12. Review
24. AKYÜZ F, MUTLUAY SOYER Ö (2017). How is gastroesophageal reflux disease classified? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol. Dec;28(Suppl 1):S10-S11. doi: 10.5152/tjg.2017.04. Review.
25. EKINCI OMER, BARAN BULENT, ORMECI AC, SOYER OM, GOKTURK S,POYANLI A, AKYUZ F, KARACA C,DEMİR K, KAYMAKOGLU S (2018). Current State and Clinical Outcome in Turkish Patients with Hepatoceluler Carsinoma. World J.Hepatol. Jan 27;10(1):51-61.
26. İLİAZ R, AKYÜZ F, YEĞEN G, ÖRMECİ A, GÖKTÜRK S, AKYÜZ Ü, BARAN B, MUTLUAY Ö, EVİRGEN S, KARACA Ç, DEMİR K, BEŞIŞIK F, GÜLLÜOĞLU M, KAYMAKOĞLU S( 2018). Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol. Jul;29(4):384-391. doi: 10.5152/tjg.2018.17491.
27. GÖKTÜRK S, AKYÜZ F, ARICI S, ALPASLAN B, ÖRMECİ A, SOYER OM, EVİRGEN S, ÇAVUŞ B, ÜZÜM AK, GÜL N, AKYÜZ Ü, KARACA Ç, DEMİR K, KAYMAKOĞLU S, SATMAN İ, BEŞIŞIK F (2018). Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux. Exp Clin Endocrinol Diabetes. 2018 Nov 20. doi: 10.1055/a-0783-2327.
B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler :
1. KARACA ÇETIN,YILMAZ EMRE,MUTLUAY SOYER ÖZLEM,ÖNEL DERYA,ÖNEL MUSTAFA, BARAN BÜLENT,ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis.
DIGESTIVE DISEASE WEEK 2013 (Poster).
2.ÖRMECI ASLI,GÖKTÜRK SUUT,AKYÜZ FILIZ,GÜLLÜOGLU MINE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2012). When we should start antiviral treatment in CMV positive
inflammatory bowel disease?. UEG WEEK 2012 (Poster).
3. DEMIR KADIR,ÖRMECI ASLI,EMRENCE ZELIHA,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,ÜSTEK DURAN (2013). Effect of Genotypic Differences in CYP2C19 and on Cure Rates for
Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors.
DIGESTIVE DISEASE WEEK 2013 (Poster)
4. ÖZDIL SADAKAT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BARAN BÜLENT,GÖKTÜRKSUUT,EVIRGEN SAMI,DEMIR KADIR (2012). Natural course in Crohn’s disease under the conventional Therapy. FALK SYMPOSIUM 2012 (Poster).
5. GÖKTÜRK SUUT,BESISIK SELMAN FATIH,ARICI SERPIL,ALPASLAN BÜSRA,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÇAVUS BILGER,KUBAT ÜZÜM AYSE,GÜL NURDAN,AKYÜZ ÜMIT, KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,SATMAN ILHAN (2014). Is Diabetes Mellitus a Risk Factor for Gastroesophageal Reflux?. DIGESTIVE DISEASE WEEK 2014 (Poster)
6. AKYÜZ FILIZ,ÖRMECI ASLI,KARACA ÇETIN,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÖRMECI TUGRUL,POYANLI ARZU,GÜLLÜOGLU MINE,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). A disease with a wide range of clinical presentation: IgG4 related disease. APASL LIVER WEEK 2013 (Poster)
7. GÖKTÜRK SUUT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,BARAN BÜLENT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2016). Efficacy of infliximab treatment in acute severe ulcerative colitis. 8th Congress of ECCO 2013 (Poster).
8. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÖRMECI ASLI,GÖKTÜRK SUUT,
EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU
SABAHATTIN,BESISIK SELMAN FATIH (2013). Treatment failure may lead to accelerated
fibrosis progression in patients with chronic hepatitis C. EASL 2013 (Poster).
9. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2013). Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus. AASLD THE LIVER MEETING 2013 (Poster).
10. GÖKTÜRK SUUT,BASAR RAFET,UÇAR ALI RIZA,BASGÖZE BARBAROS HAYRETTIN, ALTINKAYNAK MUSTAFA,BÜYÜKBALLI PINAR,ALPASLAN BÜSRA,BARAN BÜLENT,ÇIFCIBASI ÖRMECI ASLI, MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,BAKIR BARIS,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR, BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with
Genotype D Hepatitis B Infection. AASLD THE LIVER MEETING 2013 (Poster).
11. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,GÜLLÜOGLU MINE,ÖNEL DERYA,BADUR SELIM, BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2014). Entecavir and tenofovir have a comparable efficacy in treatment of nucleos(t)ide analogue naive patients with chronic
hepatitis B: A real life experience. EASL 2014 (Poster).
12. EKINCI ÖMER,BARAN BÜLENT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,EVIRGEN SAMI,POYANLI ARZU,GÜLLÜOGLU MINE,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2016). Factors associated with a higher alfafetoprotein level in patients with hepatocellular carcinoma. APASL 2016 (Poster).
13. BARAN BÜLENT,EKINCI ÖMER,MUTLUAY SOYER ÖZLEM,ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,POYANLI ARZU,GÜLLÜOGLU MINE,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2016). Comparison of prognostic scoring systems for prediction of survival in hepatocellular carcinoma. EASL 2016 (Poster).
14. GÖKTÜRK SUUT,BARAN BÜLENT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÖZDEN ILGIN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2014). Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors. THE 2014 JOINT INTERNATIONAL CONGRESS (Poster).
15. ÖZDIL SADAKAT,ÖRMECI ASLI,AKYÜZ FILIZ,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,BOZTAS GÜNGÖR, KAYMAKOGLU SABAHATTIN (2012). Do localization of inflammatory bowel disease predict
the hepatobiliary manifestation?. FALK SYMPOSIUM 2012 (Poster).
16. KAYMAKOGLU SABAHATTIN,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,BARAN BÜLENT,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,GÜREL POLAT NURAY (2013). Do antiglycan antibodies have an impact on the course of Crohn’s disease?. 8th Congress of ECCO 2013 (Poster).
17. KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,BARAN BÜLENT,ÖRMECI ASLI,GÖKTÜRK SUUT,DEMIR KADIR,ÖZDIL SADAKAT,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2012). Success of Two Different Endoscopic Submucosal Resection Methods in Gastric
Subepithelial Lesions. DIGESTIVE DISEASE WEEK 2012 (Sözlü Bildiri),
18. BARAN BÜLENT,PINARBASI SIMSEK BINNUR,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI, GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA,BADUR SELIM,GÜLLÜOGLU MINE,KAYMAKOGLU SABAHATTIN (2012). Long term outcomes of lamivudin treatment in chronic hepatitis B : Single center experience.
UEG WEEK 2012 (Poster), (Kontrol No: 2771741).
19. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,BOZBEY UGUR,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA,BADUR SELIM,GÜLLÜOGLU MINE,KAYMAKOGLU SABAHATTIN (2012). Efficacy of tenofovir in patients with lamivudine resistance is not different from nucleos(t)ide
analogue naive patients with HBeAg negative chronic hepatitis B. UEG WEEK 2012 (Poster).
20. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,ÖZDIL SADAKAT,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2012). Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients. AASLD The LIver
Meeting 2012 (Poster).
21. EKINCI ÖMER,BARAN BÜLENT,ÇIFCIBASI ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,POYANLI ARZU,GÜLLÜOGLU MINE,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Baseline alfa-fetoprotein level is a strong
predictor of vascular invasion and survival in patients with hepatocellular carcinoma.
AASLD THE LIVER MEETING 2013 (Poster).
22. AKYÜZ FILIZ,GÖKTÜRK SUUT,BARAN BÜLENT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic
Hepatitis B. AASLD THE LIVER MEETING 2013 (Poster).
23. AKYÜZ FILIZ,AKYÜZ ÜMIT,ÖRMECI ASLI,GÖKTÜRK SUUT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI, PINARBASI BINNUR,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2012). Non-small bowel lesions detected by capsule endoscopy. UEG WEEK 2012 (Poster).
24. ÖRMECI ASLI,AKYÜZ FILIZ,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ ÜMIT,ÖRMECI TUGRUL,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2012). What is the importance of capsule endoscopy in obscure
gastrointestinal bleeding and its value in predicting bleeding in the long-term?. EUG WEEK 2012 (Poster).
25. KARACA ÇETIN,ÖRMECI ASLI,BASAR RAFET,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,EVIRGEN SAMI,GÜLLÜOGLU MINE,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2013). Is APRI Score An Effective Method For The Assessment Of Fibrosis With Chronic Delta Hepatitis. APASL LIVER WEEK 2013 (Poster).
26. AKYÜZ FILIZ,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,ÖRMECI ASLI,EVIRGEN SAMI,YESIL ÖNDER SEMEN,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the LongTerm Period of
Anti-TNF Treatment?. DIGESTIVE DISEASE WEEK 2013 (Poster).
27.EVIRGEN SAMI,AKYÜZ FILIZ,UYSAL ALI RIZA,AKAN KÜBRA,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,ÇIFCIBASI ÖRMECI ASLI,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,BAKIR BARIS,POYANLI ARZU,KAYMAKOGLU SABAHATTIN (2014). Frequency of portal vein thrombos is in patients with cirrhosis of liver transplantation candidates. APASL 2014
(Poster).
28. EKINCI ÖMER,BARAN BÜLENT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,UÇAR ADEM,BAKIR BARIS,POYANLI ARZU,TÜRKMEN CÜNEYT,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Transarterial
radioembolization versus chemoembolization for thetreatment of hepatocellular carcinoma. APASL LIVER WEEK 2013 (Poster).
29. DEMIR ABDURRAHMAN,BESISIK SELMAN FATIH,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ ÜMIT, ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN,DEMIR KADIR,GÜLLÜOGLU MINE, KAYMAKOGLU SABAHATTIN,GÜL AHMET (2014). Evaluation of Small Bowel Mucosal Damage
by Capsule Endoscopy in Familial Mediterranean Fever Patients. DIGESTIVE DISEASE WEEK
2014 (Poster).
30. DEMIR KADIR,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN,AKYÜZ FILIZ,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2014). The Course of Pregnancy in Wilson's Disease -One Center,20 Years' Experience. DIGESTIVE DISEASE WEEK 2014 (Poster).
31. ILIAZ RAIM,AKYÜZ FILIZ,YEGEN GÜLÇIN,ILIAZ SINEM,ÖRMECI ASLI,GÖKTÜRK SUUT,AKYÜZ ÜMIT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR, BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2012). Does inflammation have role in the pathogenesis of irritable bowel disease. UEG WEEK 2012 (Poster).
32. ÇIFCIBASI ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,KARACA ÇETIN,GÜLLÜOGLU MINE,ÖNEL DERYA,BADUR SELIM,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). Risk factors for significant liver fibrosis in
genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT
and high serum HBVDNA levels. AASLD THE LIVER MEETING 2013 (Poster).
33. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA, GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2013). The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B. AASLD THE LIVER MEETING 2013 (Poster).
34. KAYAR YUSUF,ÖRMECI ASLI,KAYMAKOGLU SABAHATTIN,AKYÜZ FILIZ,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,BALIK EMRE,ÖZDIL SADAKAT (2012). Risk factors associated with progression to intestinal complications of Crohn's disease. UEG WEEK 2012 (Poster).
C. Yazılan ulusal/uluslararası kitaplar veya kitaplardaki bölümler:
1. GIRISIMSEL VE TEDAVI EDICI GASTROINTESTINAL ENDOSKOPI, Bölüm adı:(ENDOSKOPIK
USG KILAVUZLUGUNDA BILIYER DRENAJ) (2011)., BESISIK SELMAN FATIH,MUTLUAY SOYER
ÖZLEM, KARGER VE AVRUPA TIP KITAPÇILIK LTD. STI., Editör:PROF. DR. KADIR DEMIR DOÇ.DR. YAVUZ SELIM SARI, Basım sayısı:1, Sayfa Sayısı 540, Türkçe(Kitap Tercümesi).
2. GIRISIMSEL VE TEDAVI EDICI GASTROINTESTINAL ENDOSKOPI, Bölüm adı:(PANKREATIK
SIVI KOLEKSIYONLARININ ENDOSKOPIK ULTRASONOGRAFIK DRENAJI) (2011)., BOZTAS
GÜNGÖR,MUTLUAY SOYER ÖZLEM, KARGER VE AVRUPA TIP KITAPÇILIK LTD. STI., Editör:PROF. DR. KADIR DEMIR DOÇ. DR. YAVUZ SELIM SARI, Basım sayısı:1, Sayfa Sayısı 540, Türkçe(Kitap Tercümesi).
3. GIRISIMSEL VE TEDAVI EDICI GASTROINTESTINAL ENDOSKOPI, Bölüm adı:(PANKREATIK
SIVI KOLEKSIYONLARININ ENDOSKOPIK TEDAVISI) (2011)., BOZTAS GÜNGÖR,MUTLUAY
SOYER ÖZLEM, KARGER VE AVRUPA TIP KITAPÇILIK LTD. STI., Editör:PROF. DR. KADIR DEMIR
DOÇ. DR. YAVUZ SELIM SARI, Basım sayısı:1, Sayfa Sayısı 540, Türkçe(Kitap Tercümesi).
4. HER YÖNÜYLE SIROZ, Bölüm adı:(ALFA-1 ANTITRIPSIN EKSIKLIGI) (2012)., KARACA ÇETIN,
MUTLUAY SOYER ÖZLEM, PELIKAN YAYINCILIK, Editör:DOÇ. DR. SERIF YILMAZ, Basım sayısı:1,
Sayfa Sayısı 706, Türkçe(Bilimsel Kitap).
5. VIRAL HEPATIT 2013, Bölüm adı:(KRONIK HEPATIT B'DE INTERFERON TEDAVISI) (2013).,
MUTLUAY SOYER ÖZLEM,KAYMAKOGLU SABAHATTIN, ISTANBUL TIP KITABEVI, Editör:PROF. DR FEHMI TABAK DOÇ DR. SELMA TOSUN, Basım sayısı:1, Sayfa Sayısı 656, Türkçe(Bilimsel Kitap).
6. ENTAMOEBA HISTOLYTICA VE KLINIK/LABORATUVAR YÖNÜYLE AMIBIYAZ, Bölüm adı:
(PATOGENEZ) (2014)., MUTLUAY SOYER ÖZLEM,KAYMAKOGLU SABAHATTIN, ATLAS
KITAPÇILIK, Editör:MEHMET TANYÜKSEL, Türkçe(Bilimsel Kitap).
D. Ulusal hakemli dergilerde yayımlanan makaleler :
1. GÜMRAH MÜBECCEL,KUTOGLU KEMAL,MUTLUAY SOYER ÖZLEM,MEHTAP ÖZGÜR,YENICE NECATI (2006). Crohn hastalıgını taklit eden ince barsak karsinoid tümörü: Olgu sunumu. Akademik Gastroenteroloji.
1. Karaciger nakilli hastalarda geç dönemde kronik böbrek yetersizliği prevalans ve risk faktörleri :
EN İYİ POSTER BİLDİRİ ÖDÜLÜ, 8. ULUSAL HEPATOLOJİ KONGRESİ, 2011
2. Kronik delta hepatitli hastalarda interlökin 28B gen polimorfizminin (rs12979860 ve rs8099917) interferon tedavisine yanit üzerine etkisi:
SÖZEL BİLDİRİ İKİNCİLİK ÖDÜLÜ, 11. ULUSAL VİRAL HEPATİT KONGRESİ, 2012
3. Ülkemizde düsük H.pylori eradikasyon hizinin sorumlusu PPI dozu mu? CYP2C19 genotipik polimorfizmi etkili mi?
EN İYİ SÖZEL BİLDİRİ ÖDÜLÜ, ULUSAL GASTROENTEROLOJİ HAFTASI 2012, 2012
4. The Course of Pregnancy in Wilson’s Disease- One Center, 20 Years’Experience:
EN İYİ POSTER BİLDİRİ ÖDÜLÜ, DIGESTIVE DISEASE WEEK (DDW) 2014 , AMERIKA BİRLEŞİK DEVLETLERİ, 2014
Türk Gastroenteoloji Derneği
Türk Karaciğer Araştırması Derneği
